Skip to content

Clinical trials

Phase 2/3 Dementia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Phase 2/3 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20081
20122
20142
20153
20161
20171
20202
20212
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Active, not recruiting3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Washington University School of Medicine6
LeonaBio2
VA Office of Research and Development2
Actinogen Medical1
AstraZeneca1
Axovant Sciences Ltd.1
Janssen Research & Development, LLC1
Johns Hopkins University1
Menorah Park1
Rhode Island Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia20
Alzheimer Disease16
Brain Diseases2
Memory Disorders2
Mental Disorders2
Central Nervous System Diseases1
Cognitive Dysfunction1
Hypertension1
Lewy Body Disease1
Lymphoma, Follicular1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.